HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pneumatosis cystoides intestinalis with systemic sclerosis, limited type resulting in a poor prognosis.

Abstract
Pneumatosis cystoides intestinalis (PCI) is a rare disease characterized by the presence of multilocular intramural clusters of gas in the alimentary tract and has been considered to have a favorable response to conservative treatment. We describe the first case of limited type of systemic sclerosis (SSc) with PCI. A 74-year-old Japanese woman presented with a 4-month history of an unhealed cutaneous ulcer on the right third finger, along with sclerodactyly of bilateral hands. Proximal skin sclerosis was absent. The patient reported acute abdominal pain, and a diagnosis of PCI was established on plain radiography. The patient died of multiple organ failure 5 months after the development of PCI. PCI is rarely complicated with SSc, and all cases previously reported were associated with diffuse SSc. Because PCI is one of the poor prognostic factors of SSc, we should recognize the presence of this condition even in patients with limited cutaneous involvement.
AuthorsManabu Hamada, Miki Kayashima, Yoichi Morai, Teiichi Chi Masuda, Kazunori Urabe, Masutaka Furue
JournalThe American journal of the medical sciences (Am J Med Sci) Vol. 332 Issue 2 Pg. 100-102 (Aug 2006) ISSN: 0002-9629 [Print] United States
PMID16909060 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Fibrinolytic Agents
  • Alprostadil
Topics
  • Aged
  • Alprostadil (administration & dosage)
  • Asian People
  • Fatal Outcome
  • Female
  • Fibrinolytic Agents (administration & dosage)
  • Humans
  • Japan
  • Multiple Organ Failure (etiology)
  • Pneumatosis Cystoides Intestinalis (complications, diagnostic imaging, drug therapy, pathology)
  • Radiography
  • Scleroderma, Systemic (complications, diagnostic imaging, drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: